文献速递临床试验与 GCP医学教育与科研方法

头颈癌幸存者淋巴水肿与纤维化的自我护理:随机对照试验研究方案

Self-care for head and neck cancer survivors with lymphedema and fibrosis: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2019-12-27

本研究为三臂前瞻性随机对照试验,计划入组75例头颈癌幸存者,比较常规护理、常规护理加自我护理项目、常规护理加自我护理项目加随访三种策略。主要评估干预可行性、自我效能与依从性,以及淋巴水肿与纤维化进展、症状负担和功能状态的初步疗效。

要点

  • 头颈癌治疗后淋巴水肿与纤维化需终身自我护理,但依从性不足是可干预问题。
  • 试验采用信息-动机-行为技能模型驱动的自我护理项目,设三臂对照。
  • 目标样本75例,入组后3、6、9、12个月随访评估。

核心结论

  • 本研究旨在探索信息-动机-行为技能模型驱动的自我护理项目在头颈癌幸存者中的可行性和初步疗效。

研究设计与样本

  • 三臂前瞻性随机对照临床试验,目标样本量为75例头颈癌幸存者,年龄大于18岁。
  • 三组分别为常规护理组、常规护理加自我护理项目组、常规护理加自我护理项目加随访组。
  • 干预由培训过的工作人员提供,评估在入组时及入组后3、6、9、12个月共五个时间点进行。

主要发现

  • 原文未报告研究结果,仅报告研究方案。

关键数值与推荐

  • 结局指标包括干预可行性(实施障碍、安全性和满意度)、自我效能与自我护理依从性、以及初步疗效(淋巴水肿与纤维化进展、症状负担和功能状态)。

临床怎么用

  • 若方案可行,可能为头颈癌幸存者淋巴水肿与纤维化自我护理提供结构化干预框架。
  • 常规随访对自我护理方案依从性和保真度的潜在益处尚待本研究评估。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Head and neck cancer (HNC) patients are at high risk for developing lymphedema and fibrosis (LEF) following cancer treatment. Once HNC patients develop LEF, they need to conduct life-long self-care to slow LEF progression and reduce associated symptom burden and functional deficits. Data demonstrate that inadequate LEF self-care may be a potentially remediable issue. The objective of this study is to explore the feasibility and preliminary efficacy of an Information-Motivation-Behavioral (IMB) Skills model-driven self-care program (SCP) to improve LEF management and reduce LEF-related symptom burden and functional impairments. METHODS/DESIGN: This is a three-arm, prospective, randomized controlled clinical trial to compare: Group 1 - Usual Care, Group 2 - Usual Care Plus LEF-SCP, and Group 3 - Usual Care Plus LEF-SCP Plus Follow-Up. Participants will be HNC survivors aged > 18 years of age, who meet predefined inclusion and exclusion criteria. A sample size of 75 participants is targeted. Interventions will be provided by trained staff. The study assessments for all groups will take place at five points: study entry then 3, 6, 9, and 12 months post enrollment. Outcome measures include: (1) feasibility (barriers to implementation, safety, and satisfaction) of the proposed intervention; (2) self-efficacy and adherence to self-care; and (3) preliminary efficacy (LEF progression, symptom burden, and functional status) of the proposed intervention. DISCUSSION: This will be the first study to evaluate the feasibility of a LEF-SCP in the HNC population and its impact on self-efficacy and adherence. Furthermore, it will evaluate the potential benefit of routine follow-up on adherence and fidelity to the self-care protocol. We expect that the trial will provide evidence supporting the feasibility of a LEF self-care program. In addition, we anticipate that preliminary data will support improved outcomes including increased adherence and fidelity, and decreased LEF-associated symptoms. TRIAL REGISTRATION: ClinicalTrials.gov, a service of the US National Institute of Health (NCT03030859). Registered on 22 January 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Deng J, Dietrich MS, Murphy B, et al. Self-care for head and neck cancer survivors with lymphedema and fibrosis: study protocol for a randomized controlled trial. Trials. 2019. PMID: 31882012. doi:10.1186/s13063-019-3819-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。